Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

TOMRA: Initiating EUR 30 million cost reduction program in TOMRA Food division

In 2022, TOMRA launched a new set of financial ambitions for the coming five-year period. This includes an average annual growth rate of 15% and achieving an EBITA margin of 18% by 2027. TOMRA Food's ambition is to contribute to the Group's targets with high single-digit growth at double-digit EBITA margin. Growth prospects for automated food grading and sorting remain attractive in the medium and long term. However, both growth and profitability have been below target in 2023 as customers have been faced with a combination of challenges including difficult macroeconomic conditions and

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso

Metso Corporation’s stock exchange release on October 12, 2023, at 4:30 p.m. EESTMetso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the shareholding of BlackRock, Inc. On October 11, 2023, BlackRock's holding in Metso’s shares amounted to 39,141,862 shares or 4.72 percent of total shares and votes. BlackRock's holding through financial instruments in Metso amounted to 2,535,083 shares, which corresponds to 0.30 percent of the total amount of Metso’s shares. As a result, BlackRock's total position

Scandinavian ChemoTech's Animal Care division receives additional order from existing customer

In the past six months, Vetiqure AB has achieved great success in its launch work of the vetIQure™ TSE system around the world for the treatment of superficial tumours in dogs, cats, and horses. The Company has now received another order of 6,000 EUR from an equine hospital in Sweden.Although this individual order may be seen as small, based on the order value, it reinforces an already established trend. Since vetIQure was launched, its gentler qualities have been proven and are now appreciated by veterinarians around the world. 14 vetIQure systems are now actively being used on the market

The world’s 30 most promising cross-border payments companies

· Today, FXC Intelligence has published The Most Promising Cross-Border Payments Companies 2023 . · This is a brand new, annual market map recognising 30 of the best newer market entrants that are showing great promise for the future. · To be included on the list, companies must have shown significant growth over the past couple of years.Today, FXC Intelligence published The Most Promising Cross-Border Payments Companies for 2023. 

Brain+ announces additional commitments in the ongoing exercise of warrants of series TO 2 to reach now a coverage of almost 50%

· Brain+ has received additional new commitments from existing shareholders to exercise approximately 3.5 million warrants of series TO 2 · Including the previously announced commitments, total commitments in the TO 2 warrant exercise now covers almost 50% of the total number of warrants, corresponding to approximately DKK 2.7 million in proceeds Copenhagen, Denmark, 12 October 2023 – Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S (“Brain+” or “the Company”) announces new commitments from the company’s existing shareholders to exercise warrants in the ongoing TO 2 warrant exercise

BioStock: SynAct Pharma raises 60,5 MSEK through a directed share issue

Biotech company SynAct Pharma has decided to carry out a directed share issue of approximately 60,5 Mkr to an entity managed by Heights Capital Management. The funding enables the continued development of their primary drug candidate resomelagon. The capital will also be used for business development activites.Read the full article at biostock.se: https://www.biostock.se/en/2023/10/synact-pharma-raises-605-msek-through-a-directed-share-issue/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

The nomination committee in Gapwaves appointed

Gothenburg, October 12, 2023: According to the instructions for the nomination committee in Gapwaves which was adopted at the annual general meeting on April 26, 2019, the nomination committee, in addition to the chairman of the board, should consist of representatives of the three largest registered shareholders in terms of votes as of August 31 of the year before the year in which the annual general meeting occurs.After the three largest shareholders have each appointed a representative, the chairman of the board has convened the nomination committee for its first meeting. The nomination

Pemamek appoints Torben Blaaholm to lead wind energy segmen­­t

Pemamek Ltd., a global leader in welding and production automation solutions, announces the appointment of Torben Blaaholm as the Director of the Wind Energy Segment. The recent appointment highlights Pemamek's strong commitment to advancing PEMA wind energy solutions and dedication to the company’s strategy to improve its position in the sector globally. With over 20 years of experience in the renewable energy industry, Blaaholm brings in-depth industry knowledge and valuable expertise to the company. Blaaholm has a strong technical background in managing turnkey automation

Risk Intelligence A/S receives additional subscription commitment from Board of Directors of approx. DKK 0.45 million in the ongoing rights issue

Risk Intelligence A/S ("Risk Intelligence" or the "Company") announced on 3 October 2023, that the board of the Company resolved on a rights issue with preferential rights for the Company's existing shareholders (the "Rights Issue"). Risk Intelligence hereby announces that the Company has received an additional subscription commitment from the Board of Directors in the upcoming Rights Issue corresponding to an additional approximately DKK 0.45 million. In total the Board of Director together with management and employees have signed subscription commitments of DKK 2.1 million.Updated

CS MEDICA Announces Indian State’s FDA Approval for Two Cosmetic Products

CS MEDICA is thrilled to announce that the Indian State’s FDA has granted official approval for two cosmetic products to be marketed and sold through its subsidiary, CANNORDIC India Ltd.CS MEDICA A/S (“CS MEDICA” or “The Company”), a global MedTech company specializing in CBD and pain management, is pleased to announce a significant achievement in its Global expansion. After rigorous scrutiny, the Indian State’s FDA has granted approval for two cosmetic products with CBD from CS MEDICA, the CANNASEN[®] Anti-Hair Loss Serum and CANNASEN[®] PSOR+Atopic Lotion. Kamlesh Vora, Managing

Invitation to presentation of interim report July 1 – September 30, 2023

ADDvise Group’s interim report for the period July 1 – September 30, 2023 will be published on October 26, 2023 at 07:45 (CEST). Investors, analysts and other stakeholders are invited to a webcast and conference call at 14:00 (CEST) / 08:00 AM (EST) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will present the report.   Webcast If you wish to participate via webcast, please use the link below.   https://ir.financialhearings.com/addvise-group-q3-2023   Conference call If you wish to participate via conference call, please register via the link

Invitation to NCC’s Capital Market Day November 9, 2023

NCC welcomes investors, analysts, capital market representatives and the media to a Capital Market Day on Thursday, November 9, 2023, between 1:15 p.m. and 4:00 p.m. CET in Stockholm, Sweden.NCC’s President and CEO Tomas Carlsson will, together with the company’s Senior Management Team, present an updated picture of NCC’s operations, strategic focus and financial development. The program includes presentations from all business areas. It will be possible to ask questions in person, by telephone or via the webcast. Location: Hotel Scandic Continental, Vasagatan 22, Stockholm Agenda (

Evocative creates flexible metro network with Smartoptics ROADMs

Oslo, Norway – October 12, 2023 – Smartoptics, a leading provider of optical networking solutions, today announced that Evocative, a global Internet infrastructure provider, has chosen Smartoptics to create more flexible metro networks in various geographical serving areas. The initial Smartoptics deployment includes ROADMs, transponders, muxponders and management software for enabling ultra-low latency Ethernet services up to 400G across six data centers.Evocative is a global provider of Internet infrastructure with a full suite of colocation, network, bare metal, cloud, and managed

Second instalment of dividend

At the Annual General Meeting on 20 April 2023, it was decided that the dividend of GBP 0.345 per share/SDR would be paid out in two equal instalments. The first payment was distributed on 27 April 2023. The following dates apply to the second instalment: · Ex-dividend date is 23 October 2023 · Record date is 24 October 2023 · Distribution by Euroclear Sweden AB on 27 October 2023 For accounting purposes, the rate of exchange to be used shall be the GBP-SEK rate prevalent on the record date 23 October 2023.

Gabather Announces Completion of Phase I EEG/fMRI Target Engagement Study of GT-002 in Healthy Volunteers

STOCKHOLM, Oct. 12, 2023 -- Gabather (Nasdaq First North Growth Market: GABA), a clinical-stage pharmaceutical company aiming to transform the treatment of neuropsychiatric disorders, announced today the completion of the clinical phase of the EEG/fMRI target engagement study of GT-002 in healthy volunteers. All subjects have received the treatments, and the results show that GT-002 was well-tolerated with a favourable safety profile. The safety data confirms previous results from the two Phase 1 studies, the single ascending dose (SAD) study, and the multiple ascending dose (MAD) study with

Shape Robotics signs agreement with distributor in Greece

Shape Robotics has secured an order worth €100,000 and simultaneously entered into a distribution agreement with Netscope Solutions in Greece. The agreement spans a duration of 12 months. Greece, much like several other Central and Eastern European countries, places a strong emphasis on advancing the use of technology in education. With support from the EU's Recovery and Resilience Facility, Greece has allocated over €230 million (DKK 1.7 billion) for the establishment of STEAM classrooms, computers, interactive displays, and more. In total, in 2023, Shape Robotics has achieved

Eevia Health Plc received a 742 KSEK / 64 KEUR sales order for a Bilberry extract product

Eevia Health Plc’s (”Eevia” or ”The Company”) has received a 64 KEUR sales order from French distributor Natural Ingredients, for Feno-Myrtillus 36 organic, an organically certified bilberry extract.Natural Ingredients is a French distributor company located near Angers, in the Loire Valley. Their specialty is natural and functional ingredients for the food supplement industry.  Natural Ingredients' reputation for delivering high-quality natural products aligns perfectly with Eevia Health's mission to promote health and well-being using sustainable arctic botanical extracts. The sales

Grid Endless Aisle Powers Feridras Kiosks in Italy

OmboriGrid, in collaboration with ITAB Shop Concept, have developed a customized version of their Grid Endless Aisle solution for Feridras kiosks in DIY and home improvement stores in Italy.Feridras manufactures a wide range of bathroom furniture and accessories, which they sell via resellers throughout Italy. The company's product range is extensive, and it is not possible for any reseller to carry all the different Feridras products and variants. They wanted a solution that allowed them to showcase their entire offering, including items not currently available in-store.   To meet this

Eevia Health Plc releases a new white paper on Feno-Myrtillus® Organic, Eevia’s organic bilberry extract product line

Eevia Health Plc (”Eevia” or ”The Company”) has released a white paper featuring the Feno-Myrtillus® Organic, an organically certified and trade-name protected product line of bilberry extract.The white paper is the first of two parts. The first white paper provides a general overview of the health ingredient Feno-Myrtillus® 36 Organic, which is a highly concentrated and organically certified bilberry extract with 36% anthocyanins.  The second white paper to be released soon, does a deep dive into the science substantiating the health benefits to humans from consuming a standardized

Daugirdas Jankus becomes CEO of Hostinger Group

Daugirdas Jankus becomes CEO of Hostinger. For the past six years, he was responsible for marketing this group of companies. Arnas Stuopelis, Hostinger’s former CEO for 12 years, will continue as Chairman of the Board.“Our business is growing steadily globally, and the company culture is strong, so now is a great time for change. I am certain that Daugirdas’ visionary spirit and constant hunger for innovation will drive us towards even more ambitious goals. Daugirdas has already proved his leadership in many ways. The marketing team of nearly 200 professionals he nurtured and led has been

Gaming Innovation Group (GiG) Introduces ApuestasArgentinas.com to the Argentine Market

Gaming Innovation Group (GiG), a leading iGaming company, announces the launch of ApuestasArgentinas.com. Designed as a player-first experience, the site offers reviews and exclusive bonuses about sports betting operators in the Argentine market.The GiG team is excited to bring a world-class betting experience to the Argentine market - the launch of ApuestasArgentinas.com is another fantastic addition to GiG's portfolio and represents the trust that the company has in the developing iGaming market in Argentina, and more widely, around Latin America. The review team at ApuestasArgentinas

Bängeri Ltd. Appoints Rovio’s Hanna Valkeapää-Nokkala as New CEO to Spearhead International Expansion and Expertise Growth

  HELSINKI,12th October 2023 – Bängeri Ltd., leading Nordic consultancy specializing in the Gen Z demographic, is thrilled to announce the appointment of Hanna Valkeapää-Nokkala as its new Chief Executive Officer. Previously serving as Senior Director at Rovio Entertainment, Valkeapää-Nokkala will play a pivotal role in bolstering Bängeri’s expert consulting growth and accelerating the company’s international endeavors.   With a rich history at Rovio, Hanna oversaw the Angry Birds Brand Licensing business globally and was responsible for the company’s content business

Norconsult awarded design contract for Jotun in Sandefjord

NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY IN AUSTRALIA, CANADA, JAPAN, THE UNITED STATES OR TO US PERSONS OR IN ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. Norconsult has signed a contract to design a new binder production facility for Jotun in Gimle, Sandefjord. The task involves the general upgrade and co-location of the production plant.The initial phase of the design of the new binder production for Jotun in Gimle, Sandefjord, is expected to be completed by the

There are no items matching the current filter
There are no more items matching the current filter
Back to top